April 12 (Reuters) - Median Technologies SA ALMDT.PA :
* FY revenue from ordinary activities 6.4 million euros
($6.8 million) versus 3.9 million euros year ago
* FY operating loss 9.3 million euros versus loss of 5.7
million euros year ago
* FY net loss 9.1 million euros versus loss of 5.5 million
euros year ago
* Says new applications of Ibiopsy are foreseen, targeting
other high prevalence, costly diseases
* At Dec. 31, 2016, Co had 41.8 million euros in net cash
Source text for Eikon: urn:newsml:reuters.com:*:nBw5bxNnra
Further company coverage: ALMDT.PA
($1 = 0.9431 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))